Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Chronic Illness
|
March 7, 2008
Chronic illness, reproductive health and moral work: women's experiences of epilepsy
Diane Thompson, Hilary Thomas, Juliet Solomon, et al.
The Health Service Journal
|
October 6, 2004
Information-clinical analysis. The data today. Real-time monitoring can alert trusts to clinical performance problems--before the star-ratings do it for them
Peter Handslip, Matthew Swindells, Charles Allan, et al.
Biochimica Et Biophysica Acta
|
February 3, 2007
Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity
Helen M Coley, Fatima H Labeed, Hilary Thomas, et al.
Gynecologic Oncology
|
February 16, 2007
The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines
Helen M Coley, Christine F Shotton, Maria I Kokkinos, et al.
Social Science & Medicine (1982)
|
September 27, 2005
Dilemmas in decision-making about resuscitation--a focus group study of older people
Tushna Vandrevala, Sarah E Hampson, Tom Daly, et al.
Biophysical Journal
|
August 29, 2003
Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry
Fatima H Labeed, Helen M Coley, Hilary Thomas, et al.
Critical Care Medicine
|
March 4, 2022
Patient Harm and Institutional Avoidability of Out-of-Hours Discharge From Intensive Care: An Analysis Using Mixed Methods
Sarah Vollam, Owen Gustafson, Lauren Morgan, et al.
Nursing in Critical Care
|
February 1, 2026
Opportunities to Improve Nutrition for Patients in Hospital After Discharge From an Intensive Care Unit: A Human Factors Analysis
Sarah Vollam, Owen Gustafson, Lauren Morgan, et al.
Biochemical Pharmacology
|
August 29, 2006
Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents
Helen M Coley, Christine F Shotton, Abi Ajose-Adeogun, et al.
International Journal of Oncology
|
October 25, 2008
Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells
Matthew P Cunningham, Hilary Thomas, Christopher Marks, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Chronic Illness
|
March 7, 2008
Chronic illness, reproductive health and moral work: women's experiences of epilepsy
Diane Thompson, Hilary Thomas, Juliet Solomon, et al.
The Health Service Journal
|
October 6, 2004
Information-clinical analysis. The data today. Real-time monitoring can alert trusts to clinical performance problems--before the star-ratings do it for them
Peter Handslip, Matthew Swindells, Charles Allan, et al.
Biochimica Et Biophysica Acta
|
February 3, 2007
Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity
Helen M Coley, Fatima H Labeed, Hilary Thomas, et al.
Gynecologic Oncology
|
February 16, 2007
The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines
Helen M Coley, Christine F Shotton, Maria I Kokkinos, et al.
Social Science & Medicine (1982)
|
September 27, 2005
Dilemmas in decision-making about resuscitation--a focus group study of older people
Tushna Vandrevala, Sarah E Hampson, Tom Daly, et al.
Biophysical Journal
|
August 29, 2003
Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry
Fatima H Labeed, Helen M Coley, Hilary Thomas, et al.
Critical Care Medicine
|
March 4, 2022
Patient Harm and Institutional Avoidability of Out-of-Hours Discharge From Intensive Care: An Analysis Using Mixed Methods
Sarah Vollam, Owen Gustafson, Lauren Morgan, et al.
Nursing in Critical Care
|
February 1, 2026
Opportunities to Improve Nutrition for Patients in Hospital After Discharge From an Intensive Care Unit: A Human Factors Analysis
Sarah Vollam, Owen Gustafson, Lauren Morgan, et al.
Biochemical Pharmacology
|
August 29, 2006
Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents
Helen M Coley, Christine F Shotton, Abi Ajose-Adeogun, et al.
International Journal of Oncology
|
October 25, 2008
Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells
Matthew P Cunningham, Hilary Thomas, Christopher Marks, et al.
Page
of 5